Exhibit 10.23


 


October 22, 2020


  


Mr. Brett Monia, Ph.D.

2306 Casa Hermosa Court

Encinitas, CA 92024

bmonia523@gmull.com


  


Dear Brett:


 


Following our recent discussions,
I am pleased to invite you to join the Board of Directors of Cognition Therapeutics, Inc. (the "Company") as an outside director,
on the following basis:


 


		1.	Position. Upon your acceptance of this letter, your nomination and election as a director will
be submitted to the stockholders of the Company for approval.



 


		2.	Duties; Time Commitment. As an outside director, you will be expected to attend the meetings of
the Board of Directors and the Committees of the Board on which you serve. It is contemplated that the Board will meet in person three
times a year and by telephone three times a year and may hold special meetings from time to time, either in person or by telephone. It
is also contemplated that you will be appointed certain Committees of the Board, to be discussed at an upcoming Board meeting. It is anticipated
that each Committee of the Board will meet four times a year and as otherwise needed. Board meetings are scheduled upon prior consultation
with directors and are typically held in New York, NY. The next virtual Board dinner is currently held virtually and is scheduled for
November 1, 2020 from 4 to 6pm EST. The next Board meeting is currently scheduled for November 2, 2020, from 8:30am to 1 pm EST.



 


		3.	Compensation.



 




		a.	Annual Retainer. For so long as you continue to serve as a director of the Company, and subject
to approval by the Board, you shall be entitled to receive an annual retainer of $50,000, payable on a quarterly basis. Such retainer
shall be pro-rated for any partial year.
	 	 	 



		b.	Equity Award(s). For serving as an outside director, subject to the approval of the Board, following
your election to the Board by the Company's stockholders Company will grant to you a one-time nonqualified stock option exercisable for
the purchase of 135,000 shares of Common Stock, which will vest in four equal installments of 33,750 shares on the first, second, third
and fourth anniversaries of the date of your election to the Board, provided that you continue to serve as a director of the Company on the applicable
vesting date. If a change of control of the Company occurs prior to the termination of this stock option and before the stock option is
vested in full, this stock option will vest in full upon the closing of the change of control. The Board has also approved in principle
the grant of an additional nonqualified stock option exercisable for the purchase of 25,000 shares of Common Stock on each anniversary
date of the date of your election to the Board, which would vest in four equal annual increments provided that you continue to serve as
a director of the Company on the applicable vesting date. Each stock option will be granted under an equity incentive plan established
by the Company, and subject to your execution of a nonqualified stock option agreement, at an exercise price determined in accordance
with the equity incentive plan and applicable law; and containing such other terms and conditions as are determined by the Board. The
initial stock option is expected to have an exercise price of $.37 per share based on a recent valuation of the Company's Common Stock.



 






     


     


    

 


		4.	Expenses. The Company will pay or reimburse the reasonable, authorized expenses incurred by you
in the discharge of your duties as a director, in accordance with the general practices and policies of the Company and upon the submission
of appropriate documentation.



 


		5.	Fiduciary Obligations; Governance. The Company is governed by Delaware law. The structure. practices
and authority of the Board, including matters relating to the size and composition of the Board, the election and removal of directors,
requirements relating to Board action and the appointment of executive officers, are governed by the Company's Certificate of Incorporation
and By-laws, as each may be amended from time to time.



 


		6.	Term; Termination. This letter and your acceptance do not create a contract or promise for you
to serve as a director of the Company for a definite period of time. Therefore, you are free to resign for any reason or for no reason.
Similarly, the Company is free to conclude its relationship with you at any time in accordance with applicable law and corporate governance
principles.



 


		7.	Indemnification. The Company maintains directors and officers liability insurance. The Company
will also indemnify you under its Certificate of Incorporation and By-Laws and under a separate Indemnification Agreement between you
and the Company.



 


		8.	Proprietary Information. You agree that all information, whether or not in writing, of a private,
secret or confidential nature concerning the Company's business, business relationships or financial affairs (collectively, “Proprietary
Information”) is and shall be the exclusive property of the Company. In consideration for the Company sharing with you the
Company's Proprietary Information, you agree (a) that you will not disclose any Proprietary Information to any person or entity other
than employees or advisors of the Company or use the same for any purposes (other than in the performance of your duties as a member of
the Board) without written approval by an officer of the Company, either during or after you serve as a member of the Board, unless and
until such Proprietary Information has become public knowledge without your fault, and (b) that any materials containing Proprietary Information
which shall come into your custody or possession shall be and are the exclusive property of
the Company to be used only in the performance of your duties for the Company. All such materials or copies thereof and all tangible property
of the Company in your custody or possession shall be delivered to the Company or destroyed, at the Company's election, upon the earlier
of (i) the Company's request, or (ii) termination of your service on the Board. After such delivery or destruction, you shall not retain
any such materials or copies thereof or any such tangible property. You agree that your obligations not to disclose or to use Proprietary
Information and materials containing Proprietary Information and to return materials and tangible property also extends to such types
of information, materials and tangible property of customers of the Company or suppliers to the Company or other third parties who may
have disclosed or entrusted the same to you or the Company.



 






     


     


    

  


		9.	Independent Contractor. You will render services to the Company as an independent contractor. As
such, you will not be entitled to any benefits paid by the Company to its employees. You will be solely responsible for any tax consequences
applicable to you by reason of this appointment and your services to the Company, and the Company will not be responsible for the payment
of any federal, state or local taxes or contributions imposed under any employment insurance, social security, income tax or other tax
law or regulation with respect to your performance of services to the Company.



 


		10.	Obligations to Third Parties. You represent that your service as a member of the Board does not
and will not breach any agreement you have with any current or former employer or any other person (including without limitation any nondisclosure
or non-competition agreement), and that you will not disclose to the Company or induce the Company to use any confidential or proprietary
information or material belonging to any current or previous employer or other.



 


		11.	Governing Law. The terms of this letter shall be governed by and construed in accordance with the
laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule that would cause the application
of the laws of any jurisdiction other than the State of Delaware.



 


		12.	Successors and Assigns. This relationship is personal to you. You may not assign any of your rights
and/or obligations under this letter to any other person except as expressly permitted by the Company. The provisions of this letter shall
inure to the successors and assigns of the Company.



 


		13.	Entire Agreement; Amendment. This letter and the Indemnification Agreement supersede all previous
and contemporaneous communications, agreements and understandings, whether oral or written, between you, on the one hand, and the Company
or any of its affiliates, on the other hand, and constitute the entire agreement between you and the Company pertaining to the subject
matter hereof. The provisions of this letter may be amended only in writing and only if the writing is signed by you and authorized officer
of the Company.



 


		14.	Counterparts. This letter may be executed in two counterparts, both of which shall be considered
one and the same agreement, and shall become a binding agreement when signed by each party and delivered to
the other party. An executed counterpart of this letter may be delivered by electronic or facsimile transmission.



  


[Remainder of page intentionally blank]


 






     


     


    

 


If the foregoing is acceptable to you, please sign,
date and return a copy of this letter to the Company. The invitation set forth in this letter will expire if not accepted by November
5, 2020.


 


	 	Sincerely,
	 	 
	 	COGNITION THERAPEUTICS, INC.
	 	 
	 	By:	/s/ Robert Gailus
	 	 	Robert Gailus
	 	 	Chairman of the Board  




  


AGREED AND ACCEPTED BY:


 


	/s/ Brett Monia, Ph.D.	 	October 26, 2020
	Brett Monia, Ph.D.